Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,878 total articles
Black Rock Coffee Bar (BRCB) is trading near its 52-week low after a big pullback tied to disclosure and legal headlines. At roughly $8.04 today with a market cap around $402M and a price-to-sales below 1.0, the shares look priced for disappointment. This trade idea lays out a long entry that targets normalization of same-store trends, margin lever…
SK hynix sits squarely in the sweet spot of the AI hardware supply chain. Memory pricing volatility remains the dominant risk, but capacity discipline, rising HBM adoption and data‑center inventory normalization argue for more upside. This trade targets a measured gain with a favorable risk/reward and a strict stop to limit downside if the cycle we…
Nano Labs (NA) is a hangzhou-based fabless chip designer focused on high-throughput and high-performance computing chips, smart NICs and distributed AI infrastructure. At a $44M market cap and $1.90 share price, the stock is inexpensive by headline multiples (P/E ~1.9, P/B ~0.39) but thinly traded and volatile. This trade idea proposes a tactical s…
Firefly Aerospace offers an asymmetric long trade after a substantial share-price crash. The company still controls key small-to-medium launch hardware, has a visible backlog of commercial and government interest, and trades at what we view as distressed multiples relative to the long-term TAM for small launchers. This trade targets a recovery to $…
Blackbaud (BLKB) trades near $30 after a pullback from last year’s highs. The stock screens attractively on P/E (~10) and EV/EBITDA (~8.4) and generates strong free cash flow ($306.9M). Recent wins on AI governance integration and payments partnerships point to durable demand in education and philanthropy software. This is a tactical long idea with…
Nano Labs (NA) is a small, cash-light fabless chip designer trading at a $43M market cap and rock-bottom multiples. Recent MoU and program launches tie the business to AI data centers, Agent Cloud platforms and tokenized real-world assets — a combination that could reframe the company from a pure-play semiconductor to an AI/infra + fintech enabler.…
Snap Inc. is trading at roughly $4.62 and a market cap near $7.6B while reporting positive free cash flow and accelerating ad recoveries. The combination of a high-margin AR device strategy, tight short-interest dynamics and improving technicals argues for a long position over the next 180 trading days. This is a high-conviction, high-risk trade: e…
Nvidia's fundamentals still support premium multiples: $5.14T market cap, double-digit revenue growth potential from data-center GPUs and networking, and $119B in annual free cash flow. Its valuation - P/E ~31, P/S ~19, P/B ~25 - leaves room for a re-rate if Q2 guidance and data-center traction beat expectations. This trade idea lays out an entry a…
nCino is showing the tangible cash-flow profile SaaS investors prize. With free cash flow of $110.8M and an implied FCF margin near 18%, the company needs roughly ~22% revenue growth to clear the Rule of 40. Recent enterprise wins in Europe and APAC, plus an acquisition that strengthens integrations, make that growth path credible. This trade targe…
KT Corp. is trading at a discounted multiple (PE ~7.7, PB ~0.71) while rolling out AI-focused initiatives and riding the 5G market tailwind. Technicals show oversold conditions with early bullish MACD momentum. We upgrade to a long trade on signs management is prioritizing AI monetization; defined entry, stop and targets give a favorable risk-rewar…
AppLovin pulled back heavily in June but recent results and product catalysts argue the sell-off overshot. The company is growing revenue near 60% YoY, showing margin expansion and strong cash generation. With momentum indicators depressed and short interest modest, this is an actionable long trade: entry $450, stop $420, target $710 on a 180-day t…
Bitcoin at $40,000 offers a high-conviction long entry with defined risk. This trade plan lays out the thesis, catalysts, valuation framing and a clear stop/target structure for a long-term trade lasting up to 180 trading days.
Microsoft is doubling down on cloud and enterprise AI while trading at a mid-20s P/E and generating ~$73B in free cash flow. The setup feels like growth without paying up — a tactical long for investors who want exposure to AI/cloud exposure with a defined risk.
Leonardo is positioned to benefit from sustained European and global defense spending and its IDV (integrated digital and vehicle systems) push. We reaffirm Buy with a tactical entry at $12.00, a stop at $9.50, and a target of $16.00 over a long-term 180 trading day horizon. The setup balances upside from order flow and margin recovery with a clear…
Compass Minerals (CMP) has been through a rocky patch, but recent cash flow improvement, a reasonable EV-based valuation and operational wins in Plant Nutrition suggest the stock can re-rate. This trade idea lays out a mid-term swing long with a clearly defined entry, stop and target, plus catalysts and risks that matter.
Brookfield Infrastructure (BIP) offers a near-5% yield, inflation-linked revenue exposure and visible data-infrastructure growth, yet trades below its 52-week high with a market cap of roughly $17.6B. The business mix and recent results support steady distributable earnings growth; this trade targets total-return upside while collecting a high dist…
ServiceNow's shares have been punished on fears that agentic AI will eliminate SaaS revenue. The company's fundamentals tell a different story: 22% subscription growth, healthy free cash flow of $4.63B, low leverage and new product rollouts (Control Tower, Now Assist) that monetize AI. This trade targets a mid-term re-rate into $130 while limiting …
Opera offers a rare combo for income-focused growth traders: a semi-annual dividend yielding roughly 4% and an ad/search business that’s showing improving monetization and ARPU. At a $1.77B market cap and a mid-teens P/E, the risk/reward tilts toward buying on a pullback. This trade idea lays out entry, stop, targets and the rationale tied to produ…
Fidelity National Information Services (FIS) took a non-cash GAAP hit tied to the Worldpay divestiture, but underlying revenue and free cash flow remain robust. At roughly $41 and a P/E near 8, the market appears to be pricing permanent damage instead of a one-time accounting event. This trade idea outlines a long entry at $40.45, a stop at $36.50,…
<p>SK Hynix is the cleanest way to buy HBM exposure: a concentrated product mix, structural AI-driven demand, and tight supply create favorable pricing power. This trade idea lays out an actionable long with exact entry, stop and targets and a clear time plan for capturing the upcoming HBM-driven rerating.</p>
<p>Rheinmetall's OTC-listed Berlin ordinary shares have been hit hard recently, trading near $1,085 after a sudden drop from the $1,100s. The move looks driven more by illiquid trading dynamics and production/timing noise than a collapse in defense demand. For disciplined, risk-tolerant traders, there is an asymmetric payoff: entry around $1,085 ta…
Vicor (VICR) is benefiting from a step-change in demand for high-power-density conversion in AI and data-center infrastructure. Strong Q1 results, a $301M backlog and margin expansion argue for continued upside as the company scales capacity. This trade targets a measured long exposure at $266.16 with a $360 objective over a 180-trading-day horizon…
Marathon (MARA) is morphing from pure-play Bitcoin miner to a vertically integrated provider of powered land and compute capacity with a potential 4.8 GW campus footprint. At roughly $4.64B market cap and $1.55B cash, the stock looks mispriced versus the optionality of powered land, the Long Ridge combined-cycle plant and nascent AI/HPC contracts. …
Zenas BioPharma's obexelimab just cleared two major credibility hurdles: Phase 3 INDIGO positive results and a BLA filing. With $718.5M cash and a runway into 2029, the company can commercialize IgG4-RD while pursuing lupus and other autoimmune indications. This trade idea outlines a long entry with concrete risk controls and a 180-trading-day hori…
Runway Growth Finance (RWAY) trades at $5.31, generating a ~25% dividend yield while the market price implies a book value/NAV near $12 per share - a roughly 56% discount. The combination of a high distribution, recent SWK acquisition that expands healthcare exposure to 32% and a manageable market cap ($224m) makes RWAY an attractive income-oriente…
